A detailed history of M&T Bank Corp transactions in Moderna, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 15,973 shares of MRNA stock, worth $1.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,973
Previous 15,360 3.99%
Holding current value
$1.87 Million
Previous $1.53 Million 11.46%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$85.37 - $115.44 $52,331 - $70,764
613 Added 3.99%
15,973 $1.7 Million
Q4 2023

Feb 06, 2024

SELL
$69.51 - $104.43 $838,221 - $1.26 Million
-12,059 Reduced 43.98%
15,360 $1.53 Million
Q3 2023

Nov 02, 2023

BUY
$96.41 - $126.61 $100,844 - $132,434
1,046 Added 3.97%
27,419 $2.83 Million
Q2 2023

Aug 09, 2023

SELL
$118.5 - $160.53 $167,677 - $227,149
-1,415 Reduced 5.09%
26,373 $3.2 Million
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $495,159 - $719,123
-3,650 Reduced 11.61%
27,788 $4.27 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $3.81 Million - $6.76 Million
-32,176 Reduced 50.58%
31,438 $5.65 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $3.59 Million - $6.36 Million
30,284 Added 90.86%
63,614 $11.4 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $40,379 - $66,409
-342 Reduced 1.02%
33,330 $3.82 Million
Q2 2022

Aug 05, 2022

BUY
$117.13 - $176.59 $1.73 Million - $2.61 Million
14,777 Added 78.21%
33,672 $4.61 Million
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $447,289 - $831,371
3,537 Added 23.03%
18,895 $3.25 Million
Q4 2021

Feb 07, 2022

BUY
$225.82 - $368.51 $129,394 - $211,156
573 Added 3.88%
15,358 $3.9 Million
Q3 2021

Oct 28, 2021

BUY
$221.9 - $484.47 $165,093 - $360,445
744 Added 5.3%
14,785 $5.69 Million
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $173,819 - $314,403
1,338 Added 10.53%
14,041 $3.3 Million
Q1 2021

May 06, 2021

SELL
$109.18 - $185.98 $69,547 - $118,469
-637 Reduced 4.78%
12,703 $1.66 Million
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $57,916 - $149,646
881 Added 7.07%
13,340 $1.39 Million
Q3 2020

Nov 06, 2020

BUY
$54.34 - $94.85 $93,736 - $163,616
1,725 Added 16.07%
12,459 $881,000
Q2 2020

Jul 29, 2020

BUY
$29.67 - $80.0 $109,422 - $295,040
3,688 Added 52.34%
10,734 $688,000
Q1 2020

May 14, 2020

BUY
$17.78 - $31.58 $125,277 - $222,512
7,046 New
7,046 $211,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.